Key Insights:
- INJ enters the $10–$11 support zone, a level analysts track for potential long-term accumulation.
- RSI recovery and possible MACD crossover suggest bearish momentum easing, signaling early signs of stabilization.
- Resistance at $12.00 and $12.50 must break for INJ to confirm a stronger recovery trend.
Injective (INJ) was trading at $11.62, down 2% in the past 24 hours and 18% over the last week. Trading volume over the same period stands at $117 million. The token has now dropped into a long-term support range between $10.15 and $11.43, a level analysts have been monitoring for potential entries.
Lennaert Snyder commented on the zone, saying, “$10.15–$11.43 weekly support is the zone I’m eyeing for weeks to look for buy/longs.” He explained that while this area is suitable for accumulation, confirmation of a reversal on the 4-hour or daily charts would still be required before opening long positions.
Stabilization Around $11.50
Short-term charts show INJ holding above $11.50, where price appears to be consolidating after falling from above $12.50 earlier in the week. Moving averages on the hourly chart (5MA, 10MA, 20MA) are flattening, signaling that the sharp selling pressure is slowing.
Momentum tools are also pointing to signs of stabilization. The RSI has recovered from oversold levels and is now climbing back toward neutral territory. The MACD is turning upward, with a potential bullish crossover forming, which would confirm an early stage reversal.
Resistance Levels in Play
For a stronger recovery, INJ will need to reclaim resistance near $12.00 and then challenge the $12.50 level. Both zones are aligned with moving averages that act as short-term barriers.
Breaking above these levels could open the way for a sustained move higher. Failure to do so may leave the price consolidating or drifting lower within the $10–$11 support band.
Snyder added,
“For long-term holds this is definitely a nice zone, but for longs I’m awaiting confirmation.”
Market Attention Increasing
Social monitoring platforms reported Injective as the most mentioned ticker in the past session, according to gemxbt. This suggests that traders are closely watching how price action develops at this support zone.
DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |
Source: https://coincu.com/analysis/inj-dips-into-key-buy-zone/